572 related articles for article (PubMed ID: 17057793)
1. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
Thompson JT; Sjaarda RN
Trans Am Ophthalmol Soc; 2005; 103():98-107; discussion 107. PubMed ID: 17057793
[TBL] [Abstract][Full Text] [Related]
2. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
Hassan AS; Johnson MW; Schneiderman TE; Regillo CD; Tornambe PE; Poliner LS; Blodi BA; Elner SG
Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
[TBL] [Abstract][Full Text] [Related]
3. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
[TBL] [Abstract][Full Text] [Related]
4. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
[TBL] [Abstract][Full Text] [Related]
5. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V
J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
[TBL] [Abstract][Full Text] [Related]
6. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
Kimura S; Morizane Y; Hosokawa M; Shiode Y; Kawata T; Doi S; Matoba R; Hosogi M; Fujiwara A; Inoue Y; Shiraga F
Am J Ophthalmol; 2015 Apr; 159(4):683-9. PubMed ID: 25555798
[TBL] [Abstract][Full Text] [Related]
7. Preoperative use of tissue plasminogen activator for large submacular hemorrhage.
Chaudhry NA; Mieler WF; Han DP; Alfaro VD; Liggett PE
Ophthalmic Surg Lasers; 1999 Mar; 30(3):176-80. PubMed ID: 10100249
[TBL] [Abstract][Full Text] [Related]
8. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
Handwerger BA; Blodi BA; Chandra SR; Olsen TW; Stevens TS
Arch Ophthalmol; 2001 Jan; 119(1):28-32. PubMed ID: 11146723
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
Hay SR; Madonna RJ
Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
[TBL] [Abstract][Full Text] [Related]
10. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
Guthoff R; Guthoff T; Meigen T; Goebel W
Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
[TBL] [Abstract][Full Text] [Related]
11. Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator.
Yang PM; Kuo HK; Kao ML; Chen YJ; Tsai HH
Chang Gung Med J; 2005 Dec; 28(12):852-9. PubMed ID: 16515019
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
Schulze SD; Hesse L
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):717-20. PubMed ID: 12271367
[TBL] [Abstract][Full Text] [Related]
13. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
[TBL] [Abstract][Full Text] [Related]
14. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
Treumer F; Klatt C; Roider J; Hillenkamp J
Br J Ophthalmol; 2010 Jan; 94(1):48-53. PubMed ID: 19946027
[TBL] [Abstract][Full Text] [Related]
15. Vitreous hemorrhage complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
Wu TT; Kung YH; Hong MC
Retina; 2011 Nov; 31(10):2071-7. PubMed ID: 21817964
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
Gok M; Karabaş VL; Aslan MS; Kara Ö; Karaman S; Yenihayat F
Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
[TBL] [Abstract][Full Text] [Related]
17. Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration.
Merrill PT; LoRusso FJ; Lomeo MD; Saxe SJ; Khan MM; Lambert HM
Ophthalmology; 1999 Apr; 106(4):782-9. PubMed ID: 10201603
[TBL] [Abstract][Full Text] [Related]
18. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
Fassbender JM; Sherman MP; Barr CC; Schaal S
Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
[TBL] [Abstract][Full Text] [Related]
19. Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
Ratanasukon M; Kittantong A
Eye (Lond); 2005 Dec; 19(12):1328-32. PubMed ID: 15565185
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
Kung YH; Wu TT; Hong MC; Sheu SJ
J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
